Clinical Trial Update: SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial SP01A of an oral entry inhibitor in treatment-experienced HIV patients. The current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• SP01A

Snippet

Sponsor: Samaritan Pharmaceuticals, Inc | Conditions: HIV Infections, Human Immunodeficiency Virus | Phase 2 | Status: UNKNOWN